(Circulation. 2005;111:2210-2218.)
© 2005 American Heart Association, Inc.
Vascular Medicine |

From the Division of Cardiovascular Research and Medicine, St Elizabeths Medical Center, Tufts University School of Medicine, Boston, Mass.
Correspondence to Shin-ichiro Hayashi, MD, PhD, St Elizabeths Medical Center, Tufts University School of Medicine, 736 Cambridge St, Boston, MA 02135. E-mail shin559182{at}aol.com
Received June 27, 2004; revision received November 5, 2004; accepted December 8, 2004.
Background Ephrin-B2, one of the transmembrane ligands, is a genetic marker of arterial endothelial cells (ECs) at embryonic stages and is essential for cardiovascular development, but its roles in ischemic cardiovascular disease are not well understood. In this study, we focused on the function of ephrin-B2 in postnatal neovascularization.
Methods and Results We found that ephrin-B2 is exclusively expressed and significantly upregulated in the arterial vasculature after the initial angiogenic responses in tissue ischemia. Upregulation of ephrin-B2 is also observed in EC cordlike formation in vitro. Interestingly, ephrin-B2 expression on ECs was enhanced by promotive angiogenic growth factors, such as vascular endothelial growth factor, basic fibroblast growth factor, and hepatocyte growth factor, whereas it was attenuated by angiopoietin-1, a factor for blood vessel maturation. Moreover, an ephrin-B2rich environment was shown to induce neovascularization mainly through venous angiogenesis in an in vivo cornea micropocket assay.
Conclusions Our study indicates that the ephrin-B2 ligand is likely to have functional expression on angiogenic arterial ECs and induce a subsequent promotive effect on venous vessels during postnatal neovascularization.
Key Words: ischemia ephrin-B2 angiogenesis, postnatal endothelial cells
This article has been cited by other articles:
![]() |
A. Zeoli, P. Dentelli, A. Rosso, G. Togliatto, A. Trombetta, L. Damiano, P. F. di Celle, L. Pegoraro, F. Altruda, and M. F. Brizzi Interleukin-3 promotes expansion of hemopoietic-derived CD45+ angiogenic cells and their arterial commitment via STAT5 activation Blood, July 15, 2008; 112(2): 350 - 361. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. A. Kudo, A. Muto, S. P. Maloney, J. M. Pimiento, S. Bergaya, T. N. Fitzgerald, T. S. Westvik, J. C. Frattini, C. K. Breuer, C. H. Cha, et al. Venous Identity Is Lost but Arterial Identity Is Not Gained During Vein Graft Adaptation Arterioscler. Thromb. Vasc. Biol., July 1, 2007; 27(7): 1562 - 1571. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Limbourg, M. Ploom, D. Elligsen, I. Sorensen, T. Ziegelhoeffer, A. Gossler, H. Drexler, and F. P. Limbourg Notch Ligand Delta-Like 1 Is Essential for Postnatal Arteriogenesis Circ. Res., February 16, 2007; 100(3): 363 - 371. [Abstract] [Full Text] [PDF] |
||||
|
Circulation Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2005 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |